References
Chan KL, Teo K, Tam J, Dumesnil JG, Ni A, Tam J, for the ASTRONOMER Investigators (2010) Effect of lipid lowering with rosuvastatin on progression of aortic stenosis results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER). Trial Circ 121:306–314
Cowell J, Newly D, Prescott RJ et al (2005) A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis (SALTIRE). N Engl J Med 352:2389–2397
Rossebø AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, Gerdts E, Gohlke-Bärwolf C, Holme I, Kesäniemi YA, Malbecq W, Nienaber CA, Ray S, Skjaerpe T, Wachtell K, Willenheimer R, SEAS Investigators (2008) Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 359(13):1343–1356
Moura LM, Ramos SF, Zamorano JL et al (2007) Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. JACC 49:562–564
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Novo, G., Noto, D., Averna, M. et al. Statin therapy in patients with aortic stenosis after the ASTRONOMER trial: is there still any space?. Intern Emerg Med 7 (Suppl 1), 35–36 (2012). https://doi.org/10.1007/s11739-011-0592-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-011-0592-9